Sunil Chari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunil Chari, associated with Rossari Biotech (likely a promoter or member of the promoter group), has submitted a disclosure under Regulation 31(4) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation requires continual disclosure when a promoter or person acting in concert crosses the 5% shareholding mark or when their holding changes by more than 2% in a financial year. The filing suggests an incremental change in the disclosed entity's shareholding that has crossed one of these reporting triggers. The exact direction (purchase or sale) and specific percentage of the change are not stated in the available text.
This is a routine regulatory compliance disclosure and may indicate incremental buying or selling by a promoter group entity. Investors should watch for the detailed disclosure to understand the direction and size of the stake change, as promoter activity is often interpreted as a confidence signal.